Elligo Health Research Acquires Protenium Clinical Research; Now over 1 Million Patients Have Access to Research with Elligo
Wednesday, 09 January 2019 05:06
Jan. 9, 2019 13:00 UTC

Elligo Health Research Acquires Protenium Clinical Research; Now over 1 Million Patients Have Access to Research with Elligo

AUSTIN, Texas--(BUSINESS WIRE)-- Elligo Health Research, an integrated research organization, has acquired Protenium Clinical Research. Protenium, an established research group led by Robert Strzinek, Ph.D., D.O., conducts pharmaceutical studies in a broad range of therapeutic areas.

Dr. Strzinek has more than 15 years of clinical research experience and will now conduct research at his practice in partnership with Elligo. The acquisition brings the number of patients in Elligo’s Research Ready network to more than one million. As part of Elligo’s Goes Direct® approach, these patients will now have access to clinical research as a care option from their own trusted physician.

“Joining Elligo’s Dallas–Fort Worth Community of Research will ensure that we continue to provide the best clinical research opportunities to our patients and help us expand research opportunities across the region,” said Dr. Strzinek. “Our partnership allows us to focus on patient care while benefiting from Elligo’s research relationships and operational expertise.”

Dr. Strzinek has completed over 150 research studies and authored numerous journal articles covering several areas including endocrinology and women’s health. He and the Elligo team will continue to conduct research and support other community-based health care providers participating in research.

“The opportunity to leverage Dr. Strzinek’s highly experienced practice and integrated clinical operation in our Research Ready network and Communities of Research furthers our mission to bring together and empower health organizations and improve clinical trial access and efficiency,” said John Potthoff, Ph.D., CEO at Elligo. “We are delighted to welcome him, and his staff and patients to the Elligo family.”

About Elligo
Elligo Health Research, an integrated research organization, expands access to clinical research by bringing together health care data, community physicians and their patients. Only Elligo’s Goes Direct® approach and IntElligo Research Stack™ clinical technology — a complete standards-based technology solution — deliver better patients and improved real-time data through Elligo’s network of Research Ready sites within its Communities of Research. Learn more at elligodirect.com.


Jane Byram
SCORR Marketing
[email protected]

Source: Elligo Health Research

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!